Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells

FASEB Journal

Volumn 29, Issue 5, 2015, Pages 2150-2160

  Mauro, Loredana ^a   Pellegrino, Michele ^a   Giordano, Francesca ^a   Ricchio, Emilia ^a   Rizza, Pietro ^a   De Amicis, Francesca ^a   Catalano, Stefania ^a   Bonofiglio, Daniela ^a   Panno, Maria Luisa ^a   Andò, Sebastiano ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

AMPK; Corepressors; MAPK; Sp1; Xenografts

Indexed keywords

ADIPONECTIN; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR SP1; ESTROGEN RECEPTOR ALPHA, HUMAN; SP1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CANCER CELL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; BREAST TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; ENZYME IMMUNOASSAY; GEL MOBILITY SHIFT ASSAY; GENETICS; IMMUNOPRECIPITATION; METABOLISM; MUTATION; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALIA;

ADIPONECTIN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIN D1; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED;

EID: 84932607816     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-262808     Document Type: Article

References (45)

1. Landskroner-Eiger, S., Qian, B., Muise, E. S., Nawrocki, A. R., Berger, J. P., Fine, E. J., Koba, W., Deng, Y., Pollard, J. W., and Scherer, P. E. (2009) Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin. Cancer Res. 15, 3265-3276
2. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., Kuriyama, H., Nishida, M., Yamashita, S., Okubo, K., Matsubara, K., Muraguchi, M., Ohmoto, Y., Funahashi, T., and Matsuzawa, Y. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83
3. Obeid, S., and Hebbard, L. (2012) Role of adiponectin and its receptors in cancer. Cancer Biol. Med. 9, 213-220
4. Barb, D., Williams, C. J., Neuwirth, A. K., and Mantzoros, C. S. (2007) Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am. J. Clin. Nutr. 86, s858-s866
5. Ziemke, F., and Mantzoros, C. S. (2010) Adiponectin in insulin resistance: lessons from translational research. Am. J. Clin. Nutr. 91, 258S-261S
6. Dalamaga, M., Diakopoulos, K. N., and Mantzoros, C. S. (2012) The role of adiponectin in cancer: a review of current evidence. Endocr. Rev. 33, 547-594
7. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N. H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R., and Kadowaki, T. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769
8. Dal Maso, L., Augustin, L. S., Karalis, A., Talamini, R., Franceschi, S., Trichopoulos, D., Mantzoros, C. S., and La Vecchia, C. (2004) Circulating adiponectin and endometrial cancer risk. J. Clin. Endocrinol. Metab. 89, 1160-1163
9. Goktas, S., Yilmaz, M. I., Caglar, K., Sonmez, A., Kilic, S., and Bedir, S. (2005) Prostate cancer and adiponectin. Urology 65, 1168-1172
10. Ishikawa, M., Kitayama, J., Kazama, S., Hiramatsu, T., Hatano, K., and Nagawa, H. (2005) Plasma adiponectin and gastric cancer. Clin. Cancer Res. 11, 466-472
11. Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D. M., Papadiamantis, Y., Markopoulos, C., Spanos, E., Chrousos, G., and Trichopoulos, D. (2004) Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab. 89, 1102-1107
12. Körner, A., Pazaitou-Panayiotou, K., Kelesidis, T., Kelesidis, I., Williams, C. J., Kaprara, A., Bullen, J., Neuwirth, A., Tseleni, S., Mitsiades, N., Kiess, W., and Mantzoros, C. S. (2007) Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J. Clin. Endocrinol. Metab. 92, 1041-1048
13. Miyoshi, Y., Funahashi, T., Kihara, S., Taguchi, T., Tamaki, Y., Matsuzawa, Y., and Noguchi, S. (2003) Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res. 9, 5699-5704
14. Grossmann, M. E., Nkhata, K. J., Mizuno, N. K., Ray, A., and Cleary, M. P. (2008) Effects of adiponectin on breast cancer cell growth and signaling. Br. J. Cancer 98, 370-379
15. Wang, Y., Lam, J. B., Lam, K. S., Liu, J., Lam, M. C., Hoo, R. L., Wu, D., Cooper, G. J., and Xu, A. (2006) Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 66, 11462-11470
16. Kang, J. H., Lee, Y. Y., Yu, B. Y., Yang, B. S., Cho, K. H., Yoon, D. K., and Roh, Y. K. (2005) Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch. Pharm. Res. 28, 1263-1269
17. Planas-Silva, M. D., and Weinberg, R. A. (1997) Estrogendependent cyclin E-cdk2 activation through p21 redistribution. Mol. Cell. Biol. 17, 4059-4069
18. Prall, O. W., Rogan, E. M., and Sutherland, R. L. (1998) Estrogen regulation of cell cycle progression in breast cancer cells. J. Steroid Biochem. Mol. Biol. 65, 169-174
19. Dieudonne, M. N., Bussiere, M., Dos Santos, E., Leneveu, M. C., Giudicelli, Y., and Pecquery, R. (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 345, 271-279
20. Dos Santos, E., Benaitreau, D., Dieudonne, M. N., Leneveu, M. C., Serazin, V., Giudicelli, Y., and Pecquery, R. (2008) Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol. Rep. 20, 971-977
21. Catalano, S., Marsico, S., Giordano, C., Mauro, L., Rizza, P., Panno, M. L., and Andò, S. (2003) Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J. Biol. Chem. 278, 28668-28676
22. Mauro, L., Pellegrino, M., Lappano, R., Vivacqua, A., Giordano, F., Palma, M. G., Andò, S., and Maggiolini, M. (2010) E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor. Breast Cancer Res. Treat. 121, 79-89
23. De Amicis, F., Zupo, S., Panno, M. L., Malivindi, R., Giordano, F., Barone, I., Mauro, L., Fuqua, S. A., and Andò, S. (2009) Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter. Mol. Endocrinol. 23, 454-465
24. Mauro, L., Catalano, S., Bossi, G., Pellegrino, M., Barone, I., Morales, S., Giordano, C., Bartella, V., Casaburi, I., and Andò, S. (2007) Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res. 67, 3412-3421
25. Catalano, S., Mauro, L., Bonofiglio, D., Pellegrino, M., Qi, H., Rizza, P., Vizza, D., Bossi, G., and Andò, S. (2011) In vivo and in vitro evidence that PPARg ligands are antagonists of leptin signaling in breast cancer. Am. J. Pathol. 179, 1030-1040
26. Mauro, L., Pellegrino, M., De Amicis, F., Ricchio, E., Giordano, F., Rizza, P., Catalano, S., Bonofiglio, D., Sisci, D., Panno, M. L., and Andò, S. (2014) Evidences that estrogen receptor a interferes with adiponectin effects on breast cancer cell growth. Cell Cycle 13, 553-564
27. Fu, M., Wang, C., Li, Z., Sakamaki, T., and Pestell, R. G. (2004) Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 145, 5439-5447
28. Foster, J. S., Henley, D. C., Ahamed, S., and Wimalasena, J. (2001) Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metab. 12, 320-327
29. Catalano, S., Giordano, C., Rizza, P., Gu, G., Barone, I., Bonofiglio, D., Giordano, F., Malivindi, R., Gaccione, D., Lanzino, M., De Amicis, F., and Andò, S. (2009) Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation. J. Cell. Physiol. 218, 490-500
30. Lee, J. A., Suh, D. C., Kang, J. E., Kim, M. H., Park, H., Lee, M. N., Kim, J. M., Jeon, B. N., Roh, H. E., Yu, M. Y., Choi, K. Y., Kim, K. Y., and Hur, M. W. (2005) Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J. Biol. Chem. 280, 28061-28071
31. Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606
32. Walsh, C. A., Qin, L., Tien, J. C., Young, L. S., and Xu, J. (2012) The function of steroid receptor coactivator-1 in normal tissues and cancer. Int. J. Biol. Sci. 8, 470-485
33. Chen, X., and Wang, Y. (2011) Adiponectin and breast cancer. Med. Oncol. 28, 1288-1295
34. Urruticoechea, A., Smith, I. E., and Dowsett, M. (2005) Proliferation marker Ki-67 in early breast cancer. J. Clin. Oncol. 23, 7212-7220
35. Patani, N., Martin, L. A., and Dowsett, M. (2013) Biomarkers for the clinical management of breast cancer: international perspective. Int. J. Cancer 133, 1-13
36. Roy, P. G., and Thompson, A. M. (2006) Cyclin D1 and breast cancer. Breast 15, 718-727
37. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54, 1812-1817
38. Deepa, S. S., and Dong, L. Q. (2009) APPL1: role in adiponectin signaling and beyond. Am. J. Physiol. Endocrinol. Metab. 296, E22-E36
39. Deepa, S. S., Zhou, L., Ryu, J., Wang, C., Mao, X., Li, C., Zhang, N., Musi, N., DeFronzo, R. A., Liu, F., and Dong, L. Q. (2011) APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCzeta signaling pathway. Mol. Endocrinol. 25, 1773-1785
40. Hwang, S. L., Lu, Y., Li, X., Kim, Y. D., Cho, Y. S., Jahng, Y., Son, J. K., Lee, Y. J., Kang, W., Taketomi, Y., Murakami, M., Moon, T. C., and Chang, H. W. (2014) ERK1/2 antagonize AMPK-dependent regulation of FceRI-mediated mast cell activation and anaphylaxis. J. Allergy Clin. Immunol. 134, 714-721, e7
41. Hwang, S. L., Jeong, Y. T., Li, X., Kim, Y. D., Lu, Y., Chang, Y. C., Lee, I. K., and Chang, H. W. (2013) Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle. Br. J. Pharmacol. 169, 69-81
42. Milanini-Mongiat, J., Pouysségur, J., and Pagès, G. (2002) Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J. Biol. Chem. 277, 20631-20639
43. De Siervi, A., Marinissen, M., Diggs, J., Wang, X. F., Pages, G., and Senderowicz, A. (2004) Transcriptional activation of p21 (waf1/cip1) by alkylphospholipids: role of the mitogen-activated protein kinase pathway in the transactivation of the human p21 (waf1/cip1) promoter by Sp1. Cancer Res. 64, 743-750
44. Benasciutti, E., Pagès, G., Kenzior, O., Folk, W., Blasi, F., and Crippa, M. P. (2004) MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood 104, 256-262
45. Castro-Rivera, E., Samudio, I., and Safe, S. (2001) Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J. Biol. Chem. 276, 30853-30861